Daily non-political popular news in brief.

Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?

04-30-2007 · EurekAlert!

In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question.

Keywords: smallpox, outbreak, vaccines, protect, people, work, vaccine

« Previous | Next »

Similar news on "Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?":

Mice help researchers understand chlamydia
10-29-2007 · EurekAlert!
Genetically engineered mice may hold the key to helping scientists from Queensland University of Technology and Harvard hasten the development of a vaccine to protect adolescent girls against the most common sexually transmitted disease, chlamydia. Dr Michael Starnbach from Harvard Medical School is in Australia to work with QUT on a joint research project using a "mouse model" to study how the immune system responds to infections such as chlamydia.
Similar news · Read more »
The quest for an effective HIV vaccine presents new possibilities, challenges
05-16-2007 · EurekAlert!
A vaccine that prevents HIV infection remains an important goal in the fight against AIDS, but the current top HIV vaccine candidates may not work in this way, say scientists at NIAID. Rather, the first successful preventive HIV vaccines, if administered prior to HIV infection, may reduce HIV levels in the body, thereby delaying the progression to AIDS and the need to start antiretroviral drugs.
Similar news · Read more »
Bypassing eggs, flu vaccine grown in insect cells shows promise
04-10-2007 · EurekAlert!
An experimental flu vaccine made in insect cells -- not in eggs, where flu vaccines currently available in the United States are grown -- is safe and as effective as conventional vaccines in protecting people against the flu. Removing eggs from the flu vaccine manufacturing process could allow a vaccine to be produced in large amounts much more quickly, a key advantage if a bird flu pandemic were to occur.
Similar news · Read more »
Pneumococcal conjugate vaccines can improve the lives of HIV-infected children
11-28-2007 · EurekAlert!
An international team of experts has published the first comprehensive review of evidence on pneumococcal conjugate vaccination for children with HIV infection. Now available in the online edition of the journal Lancet Infectious Diseases, the review shows that HIV increases the risk of pneumococcal infection by up to 40 fold, that the disease is usually due to serotypes in the PCV, and that the vaccine can protect HIV-infected infants.
Similar news · Read more »
Immune response to cancer stem cells may dictate cancer's course
03-26-2007 · EurekAlert!
Mounting evidence shows that a tumor's growth and spread may depend on "cancer stem cells," which comprise only a very small subset of the tumor. A new study by Rockefeller University scientists shows that immunity to cancer stem cells may help protect people with a precancerous condition from developing the full-blown disease, and that these cells could be an important target for cancer vaccines.
Similar news · Read more »
New HIV vaccine target could solve mutation problem
11-08-2007 · EurekAlert!
While HERV are present in every cell, HIV may disrupt the normal constraints on HERV activity as it alters the cell to produce more HIV. A vaccine could be created containing HERV antigens that would stimulate T-cells targeting cells expressing HERV. Although the vaccine would not produce T-cells capable of recognizing HIV itself, it would evoke immune responses that could still protect people from becoming infected or limit the extent of damage caused by HIV.
Similar news · Read more »
First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
07-19-2007 · EurekAlert!
The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology, has yielded a new understanding of why some people can suppress virus levels following HIV infection. "The clearer picture of host responses to the virus achieved through this examination of genomes could lead to improved HIV therapies and provides new targets for vaccine developers," says Elias A. Zerhouni, M.D., director of the National Institutes of Health.
Similar news · Read more »
Cancer vaccines -- Taking a jab at cancer by stimulating the immune system
04-17-2007 · EurekAlert!
As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.
Similar news · Read more »
Academy releases emergency preparedness tools to enable millions more people to shelter in place
09-13-2007 · EurekAlert!
Although the nation has invested billions of dollars preparing to respond to emergencies, current plans leave millions of Americans at risk because they do not account for critical problems people face when they actually try to protect themselves. To fix this fundamental flaw, the New York Academy of Medicine is today releasing a report and tools -- available online -- that will enable households, work places, schools and early childhood/youth programs, and governments to anticipate and address problems they would face in emergencies.
Similar news · Read more »
Prep Work: Bird-flu vaccine might work better with primer
10-21-2006 · Science News Online
Giving people a vaccine against an existing form of avian influenza might help them respond better when given a shot for a future strain of the virus during a pandemic.
Similar news · Read more »